303 related articles for article (PubMed ID: 32212197)
1. Use of oral anticoagulation therapy in the first 3 months after the diagnosis of atrial fibrillation in Israel: A population-based study.
Kezerle L; Tsadok MA; Berliner Senderey A; Hoshen M; Leventer-Roberts M; Reges O; Leibowitz M; Haim M
J Cardiovasc Electrophysiol; 2020 Jun; 31(6):1356-1363. PubMed ID: 32212197
[TBL] [Abstract][Full Text] [Related]
2. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.
Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL
J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795
[TBL] [Abstract][Full Text] [Related]
3. Stroke-prevention strategies in North American patients with atrial fibrillation: The GLORIA-AF registry program.
McIntyre WF; Conen D; Olshansky B; Halperin JL; Hayek E; Huisman MV; Lip GYH; Lu S; Healey JS
Clin Cardiol; 2018 Jun; 41(6):744-751. PubMed ID: 29546729
[TBL] [Abstract][Full Text] [Related]
4. Racial Disparity in the Prescription of Anticoagulants and Risk of Stroke and Bleeding in Atrial Fibrillation Patients.
Tedla YG; Schwartz SM; Silberman P; Greenland P; Passman RS
J Stroke Cerebrovasc Dis; 2020 May; 29(5):104718. PubMed ID: 32122777
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and Safety of Direct Oral Anticoagulants in Relation to Temporal Changes in Their Use.
Lee SR; Choi EK; Kwon S; Jung JH; Han KD; Cha MJ; Oh S; Lip GYH
Circ Cardiovasc Qual Outcomes; 2020 Mar; 13(3):e005894. PubMed ID: 32160790
[TBL] [Abstract][Full Text] [Related]
6. Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort.
Huisman MV; Ma CS; Diener HC; Dubner SJ; Halperin JL; Rothman KJ; Teutsch C; Schoof N; Kleine E; Bartels DB; Lip GY;
Europace; 2016 Sep; 18(9):1308-18. PubMed ID: 27335063
[TBL] [Abstract][Full Text] [Related]
7. Practice Variation in Anticoagulation Prescription and Outcomes After Device-Detected Atrial Fibrillation.
Perino AC; Fan J; Askari M; Heidenreich PA; Keung E; Raitt MH; Piccini JP; Ziegler PD; Turakhia MP
Circulation; 2019 May; 139(22):2502-2512. PubMed ID: 30880434
[TBL] [Abstract][Full Text] [Related]
8. Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC. A cohort study.
Martinez C; Katholing A; Wallenhorst C; Freedman SB
Thromb Haemost; 2016 Jan; 115(1):31-9. PubMed ID: 26246112
[TBL] [Abstract][Full Text] [Related]
9. Temporal Trends in the Use and Comparative Effectiveness of Direct Oral Anticoagulant Agents Versus Warfarin for Nonvalvular Atrial Fibrillation: A Canadian Population-Based Study.
Yu AYX; Malo S; Svenson LW; Wilton SB; Hill MD
J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29080863
[TBL] [Abstract][Full Text] [Related]
10. The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015.
Alamneh EA; Chalmers L; Bereznicki LR
Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28177198
[TBL] [Abstract][Full Text] [Related]
11. Frequency and Outcomes of Reduced Dose Non-Vitamin K Antagonist Anticoagulants: Results From ORBIT-AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II).
Steinberg BA; Shrader P; Pieper K; Thomas L; Allen LA; Ansell J; Chan PS; Ezekowitz MD; Fonarow GC; Freeman JV; Gersh BJ; Kowey PR; Mahaffey KW; Naccarelli GV; Reiffel JA; Singer DE; Peterson ED; Piccini JP;
J Am Heart Assoc; 2018 Feb; 7(4):. PubMed ID: 29453305
[TBL] [Abstract][Full Text] [Related]
12. Exploring the Quality of Anticoagulant Prescribed for Patients With Atrial Fibrillation at the St John of God Hawkesbury District Health Centre, New South Wales, Australia.
Wertheimer G; Bereznicki LR
J Cardiovasc Pharmacol Ther; 2019 Jan; 24(1):46-53. PubMed ID: 29962220
[TBL] [Abstract][Full Text] [Related]
13. Site Variation and Outcomes for Antithrombotic Therapy in Atrial Fibrillation Patients After Percutaneous Coronary Intervention.
Olivier CB; Fan J; Askari M; Mahaffey KW; Heidenreich PA; Perino AC; Leef GC; Ho PM; Harrington RA; Turakhia MP
Circ Cardiovasc Interv; 2019 Aug; 12(8):e007604. PubMed ID: 31416357
[TBL] [Abstract][Full Text] [Related]
14. Flaws in Anticoagulation Strategies in Patients With Atrial Fibrillation at Hospital Discharge.
Kartas A; Samaras A; Vasdeki D; Dividis G; Fotos G; Paschou E; Forozidou E; Tsoukra P; Kotsi E; Goulas I; Efthimiadis G; Karvounis H; Tzikas A; Giannakoulas G
J Cardiovasc Pharmacol Ther; 2019 May; 24(3):225-232. PubMed ID: 30599759
[TBL] [Abstract][Full Text] [Related]
15. Trends in Atrial Fibrillation and Prescription of Oral Anticoagulants and Embolic Strokes in Germany.
Guelker JE; Bufe A; Klues H; Shin DI; Blockhaus C; Gabriel NH; Haverkamp W; Kroeger K
Cardiovasc Revasc Med; 2019 May; 20(5):399-402. PubMed ID: 30115560
[TBL] [Abstract][Full Text] [Related]
16. Sex Differences in the Use of Oral Anticoagulants for Atrial Fibrillation: A Report From the National Cardiovascular Data Registry (NCDR
Thompson LE; Maddox TM; Lei L; Grunwald GK; Bradley SM; Peterson PN; Masoudi FA; Turchin A; Song Y; Doros G; Davis MB; Daugherty SL
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28724655
[TBL] [Abstract][Full Text] [Related]
17. Underuse of Vitamin K Antagonist and Direct Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation: A Contemporary Review.
Hsu JC; Freeman JV
Clin Pharmacol Ther; 2018 Aug; 104(2):301-310. PubMed ID: 29328506
[TBL] [Abstract][Full Text] [Related]
18. Apixaban for prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation in France: The PAROS cross-sectional study of routine clinical practice.
Falissard B; Picard F; Mahe I; Hanon O; Touzé E; Danchin N; Lamy FX; Ricci L; Steg PG
Arch Cardiovasc Dis; 2019; 112(6-7):400-409. PubMed ID: 31014991
[TBL] [Abstract][Full Text] [Related]
19. Provider Specialty, Anticoagulation Prescription Patterns, and Stroke Risk in Atrial Fibrillation.
O'Neal WT; Sandesara PB; Claxton JS; MacLehose RF; Chen LY; Bengtson LGS; Chamberlain AM; Norby FL; Lutsey PL; Alonso A
J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29525778
[TBL] [Abstract][Full Text] [Related]
20. Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study.
Chao TF; Liu CJ; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Lip GYH; Chen SA
Circulation; 2018 Jul; 138(1):37-47. PubMed ID: 29490992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
